Kaspersky Lab sues the Trump administration in US court, arguing it was deprived of due process rights when DHS banned its software from US government agencies
Dustin Volz / Reuters :
Context & Ripple Effects
The lawsuit is the legal counterpunch to a six-month squeeze. First the GSA struck Kaspersky from two approved-vendor lists in July, then the administration issued a directive giving agencies 90 days to drop the software over alleged ties to the Russian government, and six days before this filing Trump signed a statutory ban into law as part of defense spending legislation.
Kaspersky's argument targets the process rather than the evidence: it claims DHS never gave it a hearing or a chance to contest the allegations before each step closed another door. That framing matters because the same playbook — listing removals, directives, then legislation — is what later produced the 2024 Commerce Department ban on Kaspersky antivirus sales nationwide.
First-order effects
- Kaspersky and DHS head to US federal court, where the company must convince a judge that administrative bans without notice or an opportunity to respond violated due process — while agencies are simultaneously purging the software under the signed law.
Second-order effects
- If Kaspersky wins procedural concessions, every future vendor exclusion built on classified or untested national-security claims gets harder; if it loses, rivals and regulators gain a template for cutting off foreign security vendors through procurement lists alone, no trial required.
Third-order effects
- The arc from GSA delisting to statute to the eventual Commerce sales ban shows national-security grounds migrating from procurement decisions into economy-wide prohibitions — with the courts positioned as the only check on how little process a foreign vendor is owed.
The trend: US treatment of foreign security software is escalating from agency-level procurement exclusions to statutory and nationwide bans, with due-process litigation as the main friction point.